LillyDirect Foundayo vs PeptidesRx
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
LillyDirect Foundayo
Best for patients with commercial insurance who want the cheapest legal brand-name GLP-1Starting at $25/mo
PeptidesRx
Best for patients prioritizing regulatory compliance in the compounded spaceStarting at $169/mo
Side-by-Side Comparison
| Feature | LillyDirect Foundayo | PeptidesRx |
|---|---|---|
| Overall Score | ✓8.5/10 | 7.9/10 |
| Starting Price | ✓$25/mo | $169/mo |
| Customer Rating | — | — |
| Features | 5 features | ✓6 features |
| States Available | ✓51 | 50 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
LillyDirect Foundayo
Pros
- ✓Cheapest legal path to a brand-name GLP-1 in 2026 ($25/mo with savings card for commercial insurance)
- ✓Direct from manufacturer — no compounding, no third-party reseller
- ✓Daily oral pill, no injections, no refrigeration
- ✓Available in all 50 states
Cons
- ✗Lower mean weight loss vs Wegovy (14.9%) and Zepbound (20.9%) — labeled-dose 11.1% per Foundayo PI
- ✗Requires existing prescription from a separate prescriber (LillyDirect does not write the prescription)
- ✗$25 savings card requires commercial insurance — Medicare and Medicaid not eligible
- ✗Strict empty-stomach 30-minute window may be hard for some patients to follow
PeptidesRx
Pros
- ✓Compliance-focused positioning vs gray-market vendors
- ✓Board-certified medical director
- ✓Transparent pricing with no surprise fees
- ✓Real prescriptions, not research-chemical channel
Cons
- ✗Smaller scale than Henry Meds or Hims
- ✗Wide peptide menu may distract from GLP-1 focus
Our Verdict
LillyDirect Foundayo edges out PeptidesRx with a higher overall score of 8.5/10 and is particularly strong for patients with commercial insurance who want the cheapest legal brand-name GLP-1. PeptidesRx remains a solid alternative, especially if you're looking for patients prioritizing regulatory compliance in the compounded space.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.